These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6162958)

  • 1. Synthesis and structure-activity relationship of spiro[isochromanpiperidine] analogues for inhibition of histamine release.
    Yamato M; Hashigaki K; Ikeda M; Ohtake H; Tasaka K
    J Med Chem; 1981 Feb; 24(2):194-8. PubMed ID: 6162958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of spiro[isochroman-piperidine] analogs for inhibition of histamine release. IV.
    Hashigaki K; Hiramatsu K; Yamato M; Tasaka K
    Chem Pharm Bull (Tokyo); 1984 Sep; 32(9):3561-8. PubMed ID: 6084557
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of spiro[isochroman-piperidine] analogs for inhibition of histamine release. III.
    Yamato M; Hashigaki K; Hiramatsu K; Tasaka K
    Chem Pharm Bull (Tokyo); 1983 Feb; 31(2):521-6. PubMed ID: 6192941
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and studies of 1,2-dihydroquinoline derivatives as inhibitors of lipid peroxidation.
    Barta-Szalai G; Gere A; Takács-Novák K; Domány G
    Arzneimittelforschung; 2003; 53(10):722-9. PubMed ID: 14650365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship of spiro[isochroman-piperidine] analogs for inhibition of histamine release. II.
    Yamato M; Hashigaki K; Tsutsumi A; Tasaka K
    Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3494-8. PubMed ID: 7340944
    [No Abstract]   [Full Text] [Related]  

  • 6. Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.
    Kubota H; Kakefuda A; Okamoto Y; Fujii M; Yamamoto O; Yamagiwa Y; Orita M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1538-44. PubMed ID: 9810691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(Indolyl-3)-1-(benzimidazolonylalkyl)-piperidines, a novel group of potential antiallergy compounds.
    Freter K; Fuchs V; Barsumian E; Oliver JT
    Arzneimittelforschung; 1985; 35(1A):272-6. PubMed ID: 2580540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of spiro[isocoumarin-piperidines] and related compounds. I.
    Yamato M; Hashigaki K; Ikeda M; Ohtake H; Tasaka K
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):402-5. PubMed ID: 6168404
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of histamine release from rat mast cells by bradykinin analogues.
    Vietinghoff G; Paegelow I; Reissmann S
    Peptides; 1996; 17(8):1467-70. PubMed ID: 8971941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats.
    Ogawa K; Nabe T; Yamamura H; Kohno S
    Eur J Pharmacol; 1999 Jun; 374(2):285-91. PubMed ID: 10422770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.
    Cross LJ; Beck-Sickinger AG; Bienert M; Gaida W; Jung G; Krause E; Ennis M
    Br J Pharmacol; 1996 Jan; 117(2):325-32. PubMed ID: 8789386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 4-alkoxy-[1'-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4'-piperidine)] analogues as histamine-3 receptor antagonists.
    Becknell NC; Dandu RR; Lyons JA; Aimone LD; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2012 Jan; 22(1):186-9. PubMed ID: 22153342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.
    Dandu RR; Lyons JA; Raddatz R; Huang Z; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2151-3. PubMed ID: 22365751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 5. Conformationally mobile analogues derived by furan ring opening.
    Martin LL; Klioze SS; Worm M; Crichlow CA; Geyer HM; Kruse H
    J Med Chem; 1979 Nov; 22(11):1347-54. PubMed ID: 533882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands: part 2.
    Caldwell JP; Matasi JJ; Fernandez X; McLeod RL; Zhang H; Fawzi A; Tulshian DB
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1164-7. PubMed ID: 19147350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiro-substituted piperidines as neurokinin receptor antagonists. I. Design and synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro [isobenzofuran-1(3H),4'piperidin]-1'-yl)butyl]-N-methylbenzamide, YM-35375, as a new lead compound for novel neurokinin receptor antagonists.
    Kubota H; Fujii M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
    Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):351-4. PubMed ID: 9501470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release from rat peritoneal mast cells.
    Imanishi N; Kawai H; Hayashi Y; Yatsunami K; Ichikawa A
    Biochem Pharmacol; 1989 Aug; 38(15):2521-6. PubMed ID: 2474295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on histamine release from rat mast cells in vitro induced by peptides. Characteristics of a synthetic intermediate with potent releasing activity.
    Roy PD; Moran DM; Bryant V; Stevenson R; Stanworth DR
    Biochem J; 1980 Oct; 191(1):233-7. PubMed ID: 6162458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of histamine release from rat mast cells in relation to the valency of the stimulating ligand.
    Healicon RM; Foreman JC
    Immunology; 1986 Apr; 57(4):611-5. PubMed ID: 2420710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors(1-6) VI. A series of new derivatives containing N,S- and N,SO2-spiro acetal scaffolds.
    Saitoh F; Nishida H; Mukaihira T; Kosuga N; Ohkouchi M; Matsusue T; Shiromizu I; Hosaka Y; Matsumoto M; Yamamoto I
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):317-23. PubMed ID: 17268108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.